At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 198 enrolled
Drug / intervention
glycopyrrolate, 1.0% +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Randomized, Double-Blind, Vehicle Controlled, Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis
In Brief
A Phase 2 clinical trial evaluating glycopyrrolate, 1.0%, glycopyrrolate, 2.0%, and 3 other interventions for Hyperhidrosis. Completed, enrolled 198 participants across 21 sites.
Detailed Summary
The purpose of this study is to evaluate the safety and efficacy of glycopyrrolate compared to vehicle for the treatment of axillary hyperhidrosis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperhidrosis
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartNov 2013
First PostedDec 2013
Primary CompletionSep 2014
TodayJul 2026
First PostedDec 20, 2013
Enrollment StartNov 1, 2013
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 12.5 years ago
Interventions
glycopyrrolate, 1.0%drug
glycopyrrolate Topical Wipes, 1.0%
glycopyrrolate, 2.0%drug
glycopyrrolate Topical Wipes, 2.0%
glycopyrrolate, 3.0%drug
glycopyrrolate Topical Wipes, 3.0%
glycopyrrolate, 4.0%drug
glycopyrrolate Topical Wipes, 4.0%
Vehicleother
Vehicle Topical Wipes